IP Interview

Mr.Sanjay Kesharwani :Patent Analyst and Patent Writer

Here is an inspiring story of Mr.Sanjay Kesharwani who is a Patent Analyst and Patent Writer by profession, particularly in the fields of Automobiles and Mechanical & General engineering fields. He is a registered patent agent in India and has over 12 years’ experience working in Indian Patent Offices,Speaking of Mr.Sanjay I remember a [...]

By |2017-09-07T15:16:52+05:30March 22nd, 2014|IP Interview|0 Comments

Workshop at Tiruvannamalai

Indian Institute Of Patent And Trademark proudly announce the name of Arunai Engineering College,Tiruvannamalai, as workshop associate for role of intellectual property rights (IPR) in life science industries. Intellectual property (IP) contributes enormously to our national and state economies. Dozens of industries across our economy rely on the adequate enforcement of their patents, trademarks, [...]

By |2017-09-07T15:14:32+05:30January 1st, 2014|IP Basics, IP Interview|0 Comments

Registration for Free Course – IP 101

Indian Institute of Patent and Trademark introduces a free certification course IP 101 which commences from March 2013. This course is conducted by IIPTA twice every year in 2 different sessions (One in spring and another in autumn). IP 101 helps students, scientists and businessmen to understand the basics of Intellectual Property Rights. This [...]

By |2017-09-07T15:06:29+05:30March 8th, 2013|IP Basics, IP Interview|0 Comments

COMPULSORY LICENSE FOR MORE DRUGS

India is again in news for its policy on compulsory license. After being in news for issuing first of a compulsory license on Nexavar, Indian government has decided to issue compulsory license for three more drugs (Indian Express news) which are related to the treatment of cancer. The three anticancer drugs that are the [...]

By |2017-09-07T14:57:42+05:30January 16th, 2013|IP Basics, IP Interview|0 Comments

ELI LILLY’S RALOXIFENE PATENTS REVOKED

Eli Lilly and Company is a global pharmaceutical company. Lilly was the first company to mass-produce penicillin, as well as one of the first pharmaceutical companies to produce human insulin using recombinant DNA, and today is the world’s largest manufacturer and distributor of psychiatric medications. Teva Pharmaceutical Industries Ltd.is an international pharmaceutical company. It [...]

By |2017-09-07T13:44:17+05:30October 22nd, 2012|India, IP Interview, Patent|0 Comments

Organization”s IP policy

In today's highly competitive IP environment, your business and IP strategiesmust be getting dressed to maximize the value of your intellectp59_ladyual property assets, work as a valuable corporate asset and a strategic business tool. Recently a magazine research indicates that over 50% of the value of many business organizations is attributed to IP. Increasing [...]

By |2017-09-07T13:38:26+05:30October 19th, 2012|IP Basics, IP Interview|0 Comments
Go to Top